Gene · 51430
SUCO: SUN domain containing ossification factor
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SUCO: SUN domain containing ossification factor. Genes, record 51430. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/51430
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9UBS9 | SUN domain-containing ossification factor | 1,254 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents20
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 2241 | Q9UBS9 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1813 | Q9UBS9 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 4517 | Q9UBS9 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 4517 | Q9UBS9 | Espacenet |
| JP 2025102886 A | 2025-07-08 | 93 | Q9UBS9 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 1813 | Q9UBS9 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 2241 | Q9UBS9 | Espacenet |
| WO 2025040788 A1 | 2025-02-27 | 26 | Q9UBS9 | Espacenet |
| JP 2024544676 A | 2024-12-03 | 26 | Q9UBS9 | Espacenet |
| EP 4441083 A2 | 2024-10-09 | 26 | Q9UBS9 | Espacenet |
1 to 10 of 20
See all 20 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,162
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SUCO papers | Newest fiscal year |
|---|---|---|---|
| ZIAAI005022 | Antibody Neutralization Mechanisms | 8 | 2025 |
| UM1AI144462 | Consortium for HIV/AIDS Vaccine Development | 7 | 2025 |
| P30GM133894 | A Synchrotron Radiation Structural Biology Resource | 6 | 2025 |
| R01CA204484 | Novel Enediyne-Based Antibody-Drug Conjugates for Cancers | 6 | 2025 |
| P01AI100148 | Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies | 5 | 2025 |
| P20GM113132 | The Institute for Biomolecular Targeting | 4 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 4 | 2025 |
| P30GM124169 | ALS Efficiently Networking Advanced Beam Line Experiments (ALS-ENABLE) | 4 | 2025 |
| UL1TR002243 | Vanderbilt Institute for Clinical and Translational Research (VICTR) | 4 | 2025 |
| ZIAAI001155 | Mechanisms of naturally-acquired immunity to malaria and clinical trials of anti-malaria monoclonal antibodies | 4 | 2025 |
1 to 10 of 1,162Source NIH's project files
See all 1,162 nih grantsPapers1,981
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Automated Multienzyme Digestion Workflows for Confident Characterization of Challenging Posttranslational Modifications in Therapeutic Antibodies by LC-MS/MS. | Rapid Commun Mass Spectrom | 2026 | 42635074 | PubTator, text mining | PubMed |
| Reconstructed amphibian heavy-chain constant regions support a mosaic origin of IgXA with IgY-like CH1-CH2, an intermediate CH3, and an IgM-like CH4. | Immunogenetics | 2026 | 42319471 | PubTator, text mining | PubMed |
| Simulation study of layer-to-layer NBTI degradation non-uniformity in GAA multi-channel nanosheet FETs. | Nanotechnology | 2026 | 42229463 | PubTator, text mining | PubMed |
| An integrated single-cell and spatial proteotranscriptomics atlas of fibroblast-driven immunoregulation within the human adult oral cavity. | Cell Press Blue | 2026 | 42147490 | PubTator, text mining | PubMed |
| Divergent disulfide bond architecture defines two IgY subclasses in snakes. | Dev Comp Immunol | 2026 | 42031188 | PubTator, text mining | PubMed |
| Kynurenine Pathway, Nrf2 and NF-κB Cross-Regulation in the CNS: An Overview. | Mol Neurobiol | 2026 | 41894093 | PubTator, text mining | PubMed |
| Targeted Inactivation of an α/β Hydrolase Gene Enables Discovery of Heterodimeric Nenestatins. | Mar Drugs | 2026 | 41892962 | PubTator, text mining | PubMed |
| High-throughput high content quantification of HIV-1 viral infectious output. | PLoS One | 2026 | 41886485 | PubTator, text mining | PubMed |
| Structure-based calculation of excipient effects on the viscosity of concentrated antibody solutions. | MAbs | 2026 | 41863436 | PubTator, text mining | PubMed |
| Cancer cell-derived sialylated IgG interacting with Siglec-7/9/10 is a potential immunotherapeutic target in pancreatic cancer. | Cell Rep Med | 2026 | 41850238 | PubTator, text mining | PubMed |
1 to 10 of 1,981
See all 1,981 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/51430
GET https://conductscience.org/api/genes/v1/51430/patents